Zeria Pharmaceutical Co., Ltd. (4559.T)

JPY 2454.0

(1.95%)

Annual Cash Flows

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow 12.18 Billion 13.15 Billion 8.95 Billion 6.89 Billion 7.25 Billion 5.5 Billion
Net Income 7.73 Billion 7.27 Billion 5.72 Billion 3.92 Billion 3.92 Billion 5.22 Billion
Depreciation & Amortization 7.55 Billion 6.14 Billion 5.4 Billion 4.43 Billion 3.94 Billion 3.73 Billion
Deferred income taxes - - - - - -
Stock-based compensation - - - - - -
Change in working capital -3.33 Billion 353.72 Million -1.24 Billion -561.61 Million 240.91 Million -1.99 Billion
Other non-cash items 17.22 Billion -617.28 Million -928.8 Million -903.06 Million -854.09 Million -1.45 Billion
Investing Cash Flow -3.95 Billion -2.57 Billion -2.89 Billion -17.46 Billion -405.11 Million -2.85 Billion
Investments in PPE -3.89 Billion -2.65 Billion -1.42 Billion -16.13 Billion -1.27 Billion -1.51 Billion
Acquisitions 815 Thousand -257.95 Million -356.69 Million -2.46 Billion -651.36 Million -429.16 Million
Investment purchases -2.29 Billion -282.71 Million -1.76 Billion -197.07 Million -1.7 Billion -1.32 Billion
Sales/Maturities of investments 2.14 Billion 340.9 Million 288.76 Million 1.37 Billion 2.51 Billion 202.08 Million
Other Investing Activities 96.39 Million 282.98 Million 361.57 Million -36.44 Million 712.25 Million 212.4 Million
Financing Cash Flow -8.12 Billion -7.41 Billion -4.84 Billion 11.18 Billion -5.87 Billion -4.53 Billion
Debt repayment -5.83 Billion -5.62 Billion -3.38 Billion -3.12 Billion -2.66 Billion -3.32 Billion
Dividends payments -1.93 Billion -1.58 Billion -1.53 Billion -1.56 Billion -1.59 Billion -1.7 Billion
Common Stock Repurchased -824 Thousand -673.92 Million -2.6 Billion -1.15 Billion -3.28 Billion -4.97 Billion
Common Stock Issuance - 6.3 Billion 2.68 Billion 17.02 Billion 1.67 Billion 5.46 Billion
Other Financing Activities -2.3 Million -5.82 Billion -2000.00 -2000.00 -2000.00 -1000.00
Accounts receivables -2.07 Billion -171 Million -2.02 Billion 825 Million 1.57 Billion 494 Million
Accounts payables 1.05 Billion -207.54 Million 284.49 Million -40.68 Million -174.21 Million -287.22 Million
Inventory -863.94 Million -150.25 Million -542.34 Million -753.88 Million 456.44 Million -751.8 Million
Other working capital -1.44 Billion 882.53 Million 1.04 Billion -592.04 Million -1.61 Billion -1.45 Billion
Cash at beginning of period 16.09 Billion 11.57 Billion 9.66 Billion 8.88 Billion 7.92 Billion 10.03 Billion
Cash at end of period 18.6 Billion 16.09 Billion 11.57 Billion 9.66 Billion 8.88 Billion 7.92 Billion
Capital Expenditure -3.89 Billion -2.65 Billion -1.42 Billion -16.13 Billion -1.27 Billion -1.51 Billion
Effect of forex changes on cash 2.4 Billion 1.34 Billion 564 Million 169.93 Million -52.09 Million -224.95 Million
Net cash flow / Change in cash 2.51 Billion 4.51 Billion 1.91 Billion 788.68 Million 960.2 Million -2.11 Billion
Free Cash Flow 8.28 Billion 10.49 Billion 7.53 Billion -9.23 Billion 5.97 Billion 3.98 Billion

Cash Flow Charts